Abstract:Following surgical resection of metastatic tumor, WBRT lowers the risk of recurrence at the original metastasis site as well as elsewhere in the brain. Recently published series of resection plus adjuvant SRS without WBRT have demonstrated one-year local control rates of 74% to 79% at the surgical bed. We analyzed our experience with post-op SRS as alternative to WBRT. Following IRB-approval, we retrospectively reviewed all patients at DHMC through September 2008 who after surgical resection underwent focal SRS to the tumor bed plus margin, deferring WBRT. All patients were treated with linear accelerator-based, isocentric, multiple arcs while immobilized within an externally fixed, BRW-stereotactic headframe. Intracranial recurrence (ICR), whether local at the surgical bed (LR) or “distant” in the brain (DR), was defined as evidence of re-growth on follow-up imaging (3-month intervals). Forty-seven patients with a total of 49 lesions underwent post-op SRS treatment between February 2002 and September 2008. Median dose to the resection cavity was 10.0 Gy (range, 8.1-20 Gy). With median follow-up 9.3 months (range, 1.1-61.4 months), actuarial local control at the resection cavity was 85.5% at 1-year, 66.9% at 2-years. Actuarial overall survivals at 1-year and 2-years were 52.5% and 31.7%, respectively. Log-rank test showed significantly shorter time to local recurrence for larger tumors, whether using diameter 2.0 cm (p = 0.04) or 3.0 cm (p = 0.05) as cut-off. Also, time to any ICR was significantly longer (p = 0.01) for metastases less than 2.0 cm size. Multivariate Cox regression of tumor size as function of cavitary dose, extent of resection, and RTOG's Graded Prognostic Assessment (GPA) showed only tumor diameter approached significance for time to ICR (p = 0.06); however, similar multivariate Cox-regression for overall survival showed only GPA correlated significantly with survival (p = 0.02). In this series, patients who underwent post-op SRS achieved excellent actuarial local control rates. Tumor size correlated significantly with time to local recurrence and with time to intracranial disease recurrence, but not with overall survival, arguing for successful salvage. We conclude that SRS to the tumor bed without WBRT is an effective treatment for resected brain metastases, especially in patients with smaller tumors. Close follow-up is advisable.

Up-front single-session radiosurgery for large brain metastases-volumetric responses and outcomes

Single-Session Gamma Knife Radiosurgery for Patients With 20 or More Brain Metastases

Single-Fraction Stereotactic Radiosurgery (SRS) Alone Versus Surgical Resection and SRS for Large Brain Metastases: A Multi-institutional Analysis

Long-term disease outcome and volume-based decision strategy in a large cohort of multiple brain metastases treated with a mono-isocentric linac-based Stereotactic Radiosurgery technique

Upfront and Repeated Stereotactic Radiosurgery in Patients With Brain Metastases From NSCLC

Single-Fraction Radiosurgery Using Conservative Doses for Brain Metastases: Durable Responses in Select Primaries With Limited Toxicity

Response of treatment-naive brain metastases to stereotactic radiosurgery

Multi-institutional retrospective review of stereotactic radiosurgery for brain metastasis in patients with small cell lung cancer without prior brain-directed radiotherapy

Surgical Resection Followed by Stereotactic Radiosurgery (S+SRS) Versus SRS Alone for Large Posterior Fossa Brain Metastases: A Comparative Analysis of Outcomes and Factors Guiding Treatment Modality Selection

Surgical resection and postoperative radiosurgery versus staged radiosurgery for large brain metastases

How many brain metastases can be treated with stereotactic radiosurgery before the radiation dose delivered to normal brain tissue rivals that associated with standard whole brain radiotherapy?

Stereotactic radiosurgery for brain metastases from small cell lung cancer without prior whole-brain radiotherapy: A meta-analysis

Toward the complete control of brain metastases using surveillance screening and stereotactic radiosurgery

Stereotactic radiosurgery using the Leksell Gamma Knife Perfexion unit in the management of patients with 10 or more brain metastases

Postoperative Stereotactic Radiosurgery (Srs) Without Whole-Brain Radiation Therapy (Wbrt) For Brain Metastases: Potential Role Of Tumor Size

Stereotactic Radiosurgery in a Small Cell Lung Cancer Patient With Numerous Brain Metastases

Selected-Lesion Stereotactic Radiosurgery (SL-SRS) as a Novel Strategy in the Treatment of Patients With Multiple Brain Metastases

Low-Dose Radiosurgery for Brain Metastases in the Era of Modern Systemic Therapy

Metastatic Neoplasm Volume Kinetics Following 2-Stage Stereotactic Radiosurgery

Single versus multiple fraction stereotactic radiosurgery for medium-sized brain metastases (4-14 cc in volume): reducing or fractionating the radiosurgery dose?

Comparative evaluation of outcomes amongst different radiosurgery management paradigms for patients with large brain metastasis